ArticleDusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi2025
The mediating role of mindfulness in the relationship between alexithymia and glycemic control in patients diagnosed with type 2 diabetes mellitus.
Article in Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study examines the impact of alexithymia and mindfulness on diabetes management, focusing on how their relationship affects glycemic control in patients with type 2 diabetes mellitus (T2DM). It evaluates the challenges posed by alexithymia in managing diabetes and the mediating role of mindfulness in this process. Method: The study included 100 T2DM patients aged 18-65 who had been diagnosed for at least one year, alongside 100 healthy controls. Data were gathered through a sociodemographic form, the Toronto Alexithymia Scale (TAS-20), and the Mindful Attention Awareness Scale (MAAS). Glycemic control was assessed using hemoglobin A1c (HbA1c) levels. Results: The prevalence of alexithymia in diabetic patients was 67%. Alexithymic individuals showed higher HbA1c levels and poorer blood sugar control (p<0.001). HbA1c levels were also significantly higher in those with lower mindfulness (p<0.001). A strong negative correlation was found between alexithymia and mindfulness (r=-0.789, p<0.001). TAS-20 scores significantly correlated with HbA1c (β=0.508, p<0.001), while higher MAAS scores were linked to better glycemic control (β=-0.674, p<0.001). When MAAS was included in the model, the direct relationship between TAS-20 and HbA1c lost significance (β=-0.024, p=0.85), indicating a mediating role of mindfulness. Conclusion: Mindfulness was associated with better diabetes management and glycemic control and glycemic control in individuals with alexithymia symptoms. Incorporating mindfulness-based strategies into psychosocial interventions could enhance quality of life and treatment adherence for these patients, underscoring the need for a holistic approach to diabetes care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.